Growth Metrics

Omeros (OMER) Cash from Investing Activities (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -74.24%
Dec 31, 2025 1,725.80%
Sep 30, 2025 -132.22%
Jun 30, 2025 -44.74%
Mar 31, 2025 10.26%
Dec 31, 2024 -3.01%
Sep 30, 2024 -50.73%
Jun 30, 2024 218.13%
Mar 31, 2024 -153.27%
Dec 31, 2023 103.34%
Sep 30, 2023 61.60%
Jun 30, 2023 119.51%
Mar 31, 2023 -67.14%
Dec 31, 2022 -428.77%
Sep 30, 2022 33.38%
Jun 30, 2022 132.21%
Mar 31, 2022 -168.33%
Dec 31, 2021 528.17%
Sep 30, 2021 -41.15%
Jun 30, 2021 -7.80%
Mar 31, 2021 312.52%
Dec 31, 2020 106.75%
Sep 30, 2020 -463.25%
Jun 30, 2020 202.47%
Mar 31, 2020 127.46%
Dec 31, 2019 -520.16%
Sep 30, 2019 -38.61%
Jun 30, 2019 34.77%
Mar 31, 2019 578.06%
Dec 31, 2018 -107.14%
Sep 30, 2018 334.51%
Jun 30, 2018 -264.96%
Mar 31, 2018 57.35%
Dec 31, 2017 109.12%
Sep 30, 2017 -1,118.47%
Jun 30, 2017 -45.18%
Mar 31, 2017 277.41%
Dec 31, 2016 70.74%
Sep 30, 2016 -365.13%
Jun 30, 2016 -130.18%
Mar 31, 2016 96.48%
Dec 31, 2015 -48.33%
Sep 30, 2015 -26.54%
Jun 30, 2015 131.60%
Mar 31, 2015 -528.73%
Dec 31, 2014 -2.72%
Sep 30, 2014 -5.17%
Jun 30, 2014 140.35%
Mar 31, 2014 -688.31%
Dec 31, 2013 -147.23%
Sep 30, 2013 265.56%
Jun 30, 2013 -172.49%
Mar 31, 2013 4.50%
Dec 31, 2012 128.09%
Sep 30, 2012 -4,097.17%
Jun 30, 2012 -96.23%
Mar 31, 2012 167.40%
Dec 31, 2011 55.15%
Sep 30, 2011 -26.91%
Jun 30, 2011 485.79%
Mar 31, 2011 76.13%
Dec 31, 2010 -198.68%